当前位置: X-MOL 学术Acta Neuropathol. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Correction: Abeta targets of the biosimilar antibodies of Bapineuzumab, Crenezumab, Solanezumab in comparison to an antibody against N-truncted Abeta in sporadic Alzheimer disease cases and mouse models
Acta Neuropathologica ( IF 12.7 ) Pub Date : 2024-03-25 , DOI: 10.1007/s00401-024-02718-w
Yvonne Bouter , Jose Socrates Lopez Noguerola , Petra Tucholla , Gabriela A. N. Crespi , Michael W. Parker , Jens Wiltfang , Luke A. Miles , Thomas A. Bayer



中文翻译:

修正:在散发性阿尔茨海默病病例和小鼠模型中,Bapineuzumab、Crenezumab、Solanezumab 生物仿制药抗体的 Abeta 靶点与针对 N 截断 Abeta 的抗体相比

更新日期:2024-03-25
down
wechat
bug